Elucidating dietary fructose and alcohol interactions during liver cancer development
阐明肝癌发展过程中膳食果糖和酒精的相互作用
基本信息
- 批准号:10833393
- 负责人:
- 金额:$ 7.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Acetate-CoA LigaseAcetatesAcetyl Coenzyme AAlcoholic steatohepatitisAlcoholsAwardBloodCancer BiologyCancer and NutritionCell Differentiation processCommunicationCytotoxic T-LymphocytesDendritic CellsDevelopmentEnsureEnzymesFructoseFundingGrowthImmunologyImmunosuppressionKnowledgeLeadLife StyleLipidsMalignant NeoplasmsMalignant neoplasm of liverMediatingMentorsMentorshipMetabolicMetabolic DiseasesNational Institute on Alcohol Abuse and AlcoholismParentsPathway interactionsPolyunsaturated Fatty AcidsPrimary carcinoma of the liver cellsProductionProteinsResearchResearch Project GrantsRiskRoleScientistSerumTechniquesTrainingVery Long Chain Fatty AcidViralViral hepatitisViruscarcinogenicitycareercareer developmentdiagnostic biomarkerdietaryexperienceexperimental studygraduate studentgut microbiotaimmunoregulationmembermetabolomicsnonalcoholic steatohepatitisparent grantpreventsenior facultyskillsstemsupplemental instructiontumortumor growthunderrepresented minority student
项目摘要
PROJECT SUMMARY/ABSTRACT
The primary objective of this NIAAA R01 Supplement is to equip Ms. Miranda Lopez, an underrepresented
graduate student candidate, with the skills and knowledge necessary to become a proficient and independent
scientist while completing her proposed research project on deciphering mechanisms of alcohol/fructose-
induced hepatocellular carcinoma (HCC), a natural extension of the parent R01 award. Dr. Cholsoon Jang, the
lead mentor, and Dr. Dequina Nicholas, the co-mentor, possess the requisite proficiency and knowledge to
offer an optimal co-mentorship for both the accomplishment of her project and her career growth. Specifically,
Dr. Jang has expertise in nutrition and cancer biology and Dr. Nicholas has expertise in immunology and has
plenty of experience in mentoring underrepresented minority students. Further, to ensure Ms. Lopez's career
development, we have enlisted two senior faculty members to serve on her mentoring committee. During the
diversity supplement period, Ms. Lopez will perform experiments to determine the role of specific lipid pathway
in alcohol/fructose-induced HCC (Candidate Aim 1). She will also determine whether immunomodulation is
involved in HCC tumor growth (Candidate Aim 2). Both aims are a natural extension of Aim 1 of the parent
award: “whether and how fructose and alcohol synergistically increase HCC risk”. Although antiviral treatment
has proven effective in preventing virus-associated HCC, the origin of the cancer is now transitioning from viral
hepatitis to metabolic disorders that stem from lifestyle choices, including non-alcoholic and alcoholic
steatohepatitis. In the parent award, we hypothesized that fructose shifts the metabolic fate of alcohol toward
carcinogenic metabolite production via induction of acetyl-CoA synthetase 2 (ACSS2), a cytosolic enzyme that
catabolizes acetate to acetyl-CoA. In Aim 1, we aim to determine whether and how fructose and alcohol
synergistically increase HCC risk. In Aim 2, we aim to determine whether ACSS2 inhibition and/or gut
microbiota depletion suppresses fructose and alcohol-induced HCC. In Aim 1 of the parent grant, we
discovered, by our unbiased untargeted metabolomic, that alcohol/fructose-induced HCC showed a profound
accumulation of very long-chain polyunsaturated fatty acids (VLC-PUFA). Furthermore, blood VLC-PUFA
strongly correlates with HCC burden, suggesting an exciting possibility of using serum VLC-PUFA as an HCC
diagnostic marker. VLC-PUFA are synthesized by ELOVL2 (elongation of very long chain fatty acids protein 2),
and we found that ELOVL2 proteins are 3-fold higher in tumors. Recently, VLC-PUFA has been shown to inhibit
dendritic cell differentiation and reduce cytotoxic T cells. Therefore, Mr. Lopez will determine whether blocking
ELOVL2 suppresses alcohol/fructose-induced HCC and whether VLC-PUFA-mediated immune suppression is
the key underlying mechanisms of HCC progression. As she undertakes the proposed research, she will receive
a broad range of training, including developing expertise in experimental techniques, cultivating research
independence, honing her scientific communication skills, and mastering the art of grantsmanship, among others.
项目总结/摘要
这份NIAAA R 01补充材料的主要目标是为代表性不足的米兰达·洛佩斯女士提供装备
研究生候选人,与必要的技能和知识,成为一个熟练和独立的
科学家在完成她提出的关于破译酒精/果糖机制的研究项目时,
诱导的肝细胞癌(HCC),是母体R 01奖的自然延伸。张哲顺博士
首席导师和共同导师Dequina Nicholas博士拥有必要的熟练程度和知识,
为她的项目完成和职业发展提供最佳的共同指导。具体地说,
博士Jang在营养和癌症生物学方面拥有专业知识,Nicholas博士在免疫学方面拥有专业知识,并已
在指导少数族裔学生方面有丰富的经验。另外,为了确保洛佩斯女士的事业
为了发展,我们招募了两名资深教师担任她的指导委员会成员。期间
多样性补充期间,洛佩斯女士将进行实验,以确定特定脂质途径的作用
在酒精/果糖诱导的HCC中(候选目标1)。她还将确定免疫调节是否
参与HCC肿瘤生长(候选目标2)。这两个目标都是母公司目标1的自然延伸
奖项:“果糖和酒精是否以及如何协同增加HCC风险”。虽然抗病毒治疗
已经证明有效预防病毒相关的HCC,癌症的起源现在正在从病毒转变为病毒
肝炎到代谢紊乱源于生活方式的选择,包括非酒精和酒精
脂肪性肝炎在父母奖中,我们假设果糖将酒精的代谢命运转向
通过诱导乙酰辅酶A合成酶2(ACSS 2)产生致癌代谢物,ACSS 2是一种细胞溶质酶,
将乙酸分解代谢为乙酰辅酶A。在目标1中,我们的目标是确定果糖和酒精
协同增加HCC风险。在目标2中,我们的目标是确定ACSS 2抑制和/或肠
微生物群耗竭抑制果糖和酒精诱导的HCC。在家长补助金的目标1中,我们
通过我们无偏见的非靶向代谢组学发现,酒精/果糖诱导的HCC显示出深刻的
极长链多不饱和脂肪酸(VLC-PUFA)的积累。血液VLC-PUFA
与HCC负荷密切相关,这表明使用血清VLC-PUFA作为HCC负荷的令人兴奋的可能性。
诊断标志物VLC-PUFA由VL 2(延长极长链脂肪酸蛋白2)合成,
我们发现在肿瘤中,CD 3VL 2蛋白的表达要高出3倍。最近,VLC-PUFA已显示出抑制
树突状细胞分化和减少细胞毒性T细胞。因此,洛佩斯先生将决定是否阻止
HPLC-VL 2抑制酒精/果糖诱导的HCC以及VLC-PUFA介导的免疫抑制是否
HCC进展的关键潜在机制。当她进行拟议的研究时,她将收到
广泛的培训,包括发展实验技术的专业知识,培养研究
独立性,磨练她的科学沟通技巧,并掌握granecraft的艺术,等等。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Metabolic flux between organs measured by arteriovenous metabolite gradients.
- DOI:10.1038/s12276-022-00803-2
- 发表时间:2022-09
- 期刊:
- 影响因子:12.8
- 作者:Bae, Hosung;Lam, Katie;Jang, Cholsoon
- 通讯作者:Jang, Cholsoon
Dietary Fructose and Fructose-Induced Pathologies.
饮食果糖和果糖诱导的病理。
- DOI:10.1146/annurev-nutr-062220-025831
- 发表时间:2022-08-22
- 期刊:
- 影响因子:8.9
- 作者:
- 通讯作者:
Circulating metabolite homeostasis achieved through mass action.
- DOI:10.1038/s42255-021-00517-1
- 发表时间:2022-01
- 期刊:
- 影响因子:20.8
- 作者:Li, Xiaoxuan;Hui, Sheng;Mirek, Emily T.;Jonsson, William O.;Anthony, Tracy G.;Lee, Won Dong;Zeng, Xianfeng;Jang, Cholsoon;Rabinowitz, Joshua D.
- 通讯作者:Rabinowitz, Joshua D.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cholsoon Jang其他文献
Cholsoon Jang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cholsoon Jang', 18)}}的其他基金
Elucidating alcohol-induced metabolic remodeling of critical organs
阐明酒精诱导的关键器官代谢重塑
- 批准号:
10667050 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Elucidating dietary fructose and alcohol interactions during liver cancer development
阐明肝癌发展过程中膳食果糖和酒精的相互作用
- 批准号:
10454804 - 财政年份:2021
- 资助金额:
$ 7.15万 - 项目类别:
Elucidating dietary fructose and alcohol interactions during liver cancer development
阐明肝癌发展过程中膳食果糖和酒精的相互作用
- 批准号:
10627856 - 财政年份:2021
- 资助金额:
$ 7.15万 - 项目类别:
Elucidating dietary fructose and alcohol interactions during liver cancer development
阐明肝癌发展过程中膳食果糖和酒精的相互作用
- 批准号:
10184696 - 财政年份:2021
- 资助金额:
$ 7.15万 - 项目类别:
相似海外基金
Development of palladium-catalyzed novel organic transformations of silylated allyl acetates
钯催化的硅烷化乙酸烯丙酯新型有机转化的开发
- 批准号:
18K05101 - 财政年份:2018
- 资助金额:
$ 7.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biosynthesis of Methylketones and 2-Alkany l Acetates
甲基酮和 2-烷酰基乙酸酯的生物合成
- 批准号:
9118188 - 财政年份:1992
- 资助金额:
$ 7.15万 - 项目类别:
Standard Grant